{"transactions":[{"id":1021983,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74449,"kind":"person","name":"Goode Paul","position":1,"cik":"0001622251","reported_name":"Goode Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-10-07T23:26:08.000Z","date":"2025-03-25","kind":"other","planned":false,"acquired":true,"shares":42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 7, 2022, the reporting person entered into an into Intellectual Property Purchase Agreement (the \"IP Purchase Agreement\") with Glucotrack, Inc. (the \"Issuer\"), pursuant to which the reporting person is entitled to certain specified milestone payments, payable in common stock, par value $0.001 per share, of the Issuer (the \"Common Stock\"), as set forth in the IP Purchase Agreement. Upon the achievement of the third milestone contemplated by the IP Purchase Agreement, the reporting person was issued 42 shares of Common Stock, pursuant to the terms of the IP Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 7, 2022, the reporting person entered into an into Intellectual Property Purchase Agreement (the \"IP Purchase Agreement\") with Glucotrack, Inc. (the \"Issuer\"), pursuant to which the reporting person is entitled to certain specified milestone payments, payable in common stock, par value $0.001 per share, of the Issuer (the \"Common Stock\"), as set forth in the IP Purchase Agreement. Upon the achievement of the third milestone contemplated by the IP Purchase Agreement, the reporting person was issued 42 shares of Common Stock, pursuant to the terms of the IP Purchase Agreement."}],"balance_after":339,"source":{"system":"sec-edgar","filing":"0001622251-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000162225125000002/primary_doc.xml","form_type":"4"}},{"id":1022007,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74453,"kind":"person","name":"Balo Andrew K","position":1,"cik":"0001323190","reported_name":"Balo Andrew K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-10-07T21:38:38.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":4055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option grant has a vesting commencement date of July 1 of the applicable calendar year and vests in 12 equal monthly installments over the 12-month period ending June 30 of the following year, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":4055,"derivative":{"exercise_price":7.4,"expiration_date":"2035-10-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":4055},"source":{"system":"sec-edgar","filing":"0001323190-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1323190/000132319025000003/primary_doc.xml","form_type":"4"}},{"id":1022006,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74453,"kind":"person","name":"Balo Andrew K","position":1,"cik":"0001323190","reported_name":"Balo Andrew K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-10-07T21:38:38.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":1285,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4692,"source":{"system":"sec-edgar","filing":"0001323190-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1323190/000132319025000003/primary_doc.xml","form_type":"4"}},{"id":1022005,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74453,"kind":"person","name":"Balo Andrew K","position":1,"cik":"0001323190","reported_name":"Balo Andrew K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-10-07T21:38:38.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":3332,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3407,"source":{"system":"sec-edgar","filing":"0001323190-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1323190/000132319025000003/primary_doc.xml","form_type":"4"}},{"id":1022004,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74453,"kind":"person","name":"Balo Andrew K","position":1,"cik":"0001323190","reported_name":"Balo Andrew K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-10-07T21:38:38.000Z","date":"2025-03-25","kind":"grant","planned":false,"acquired":true,"shares":75,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75,"source":{"system":"sec-edgar","filing":"0001323190-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323190/000132319025000003/primary_doc.xml","form_type":"4"}},{"id":1021988,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-10-07T21:06:05.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":4055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option grant has a vesting commencement date of July 1 of the applicable calendar year and vests in 12 equal monthly installments over the 12-month period ending June 30 of the following year, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":4055,"derivative":{"exercise_price":7.4,"expiration_date":"2035-10-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":4055},"source":{"system":"sec-edgar","filing":"0001395781-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000139578125000002/primary_doc.xml","form_type":"4"}},{"id":1021987,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-10-07T21:06:05.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":463,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4058,"source":{"system":"sec-edgar","filing":"0001395781-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000139578125000002/primary_doc.xml","form_type":"4"}},{"id":1021986,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-10-07T21:06:05.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3595,"source":{"system":"sec-edgar","filing":"0001395781-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000139578125000002/primary_doc.xml","form_type":"4"}},{"id":1021985,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-10-07T21:06:05.000Z","date":"2025-03-25","kind":"grant","planned":false,"acquired":true,"shares":35,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2395,"source":{"system":"sec-edgar","filing":"0001395781-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000139578125000002/primary_doc.xml","form_type":"4"}},{"id":1022338,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-10-07T20:58:44.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":4055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option grant has a vesting commencement date of July 1 of the applicable calendar year and vests in 12 equal monthly installments over the 12-month period ending June 30 of the following year, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":4055,"derivative":{"exercise_price":7.4,"expiration_date":"2035-10-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":4055},"source":{"system":"sec-edgar","filing":"0001993078-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000199307825000003/primary_doc.xml","form_type":"4"}},{"id":1022337,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-10-07T20:58:44.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":386,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2148,"source":{"system":"sec-edgar","filing":"0001993078-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000199307825000003/primary_doc.xml","form_type":"4"}},{"id":1022336,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-10-07T20:58:44.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1762,"source":{"system":"sec-edgar","filing":"0001993078-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000199307825000003/primary_doc.xml","form_type":"4"}},{"id":1022335,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-10-07T20:58:44.000Z","date":"2025-03-25","kind":"grant","planned":false,"acquired":true,"shares":32,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":762,"source":{"system":"sec-edgar","filing":"0001993078-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000199307825000003/primary_doc.xml","form_type":"4"}},{"id":1187745,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81415,"kind":"organization","name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","position":1,"cik":"0002046615","reported_name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Common Warrant","published_at":"2025-03-31T13:20:04.000Z","date":"2025-03-12","kind":"other","planned":false,"acquired":false,"shares":132036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On November 14, 2024, in connection with the Conversion, the Ballantyne Trust was issued Series A Common Warrants to purchase Common Stock and Series B Common Warrants to purchase Common Stock, each at an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On March 12, 2025, the Ballantyne Trust effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via warrant exchange for 2,560,553 shares of Common Stock."},{"field":"kind","element":"transactionCoding","label":"F4","text":"On March 12, 2025, the Ballantyne Trust effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via warrant exchange for 2,560,553 shares of Common Stock."}],"balance_after":0,"derivative":{"exercise_date":"2025-01-03","expiration_date":"2027-07-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":2560553},"source":{"system":"sec-edgar","filing":"0001474506-25-000073","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000073/primary_doc.xml","form_type":"4"}},{"id":1187744,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81415,"kind":"organization","name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","position":1,"cik":"0002046615","reported_name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Common Warrant","published_at":"2025-03-31T13:20:04.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":132036,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On November 14, 2024, in connection with the Conversion, the Ballantyne Trust was issued Series A Common Warrants to purchase Common Stock and Series B Common Warrants to purchase Common Stock, each at an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 14, 2024, in connection with the Conversion, the Ballantyne Trust was issued Series A Common Warrants to purchase Common Stock and Series B Common Warrants to purchase Common Stock, each at an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."}],"balance_after":132036,"derivative":{"exercise_price":5.6,"exercise_date":"2025-01-03","expiration_date":"2027-07-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":2560553},"source":{"system":"sec-edgar","filing":"0001474506-25-000073","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000073/primary_doc.xml","form_type":"4"}},{"id":1187743,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81415,"kind":"organization","name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","position":1,"cik":"0002046615","reported_name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Common Warrant","published_at":"2025-03-31T13:20:04.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":132036,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 14, 2024, in connection with the Conversion, the Ballantyne Trust was issued Series A Common Warrants to purchase Common Stock and Series B Common Warrants to purchase Common Stock, each at an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."}],"balance_after":132036,"derivative":{"exercise_price":5.6,"exercise_date":"2025-01-03","expiration_date":"2030-01-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":132036},"source":{"system":"sec-edgar","filing":"0001474506-25-000073","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000073/primary_doc.xml","form_type":"4"}},{"id":1187742,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81415,"kind":"organization","name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","position":1,"cik":"0002046615","reported_name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2025-03-31T13:20:04.000Z","date":"2024-07-30","kind":"purchase","planned":false,"acquired":true,"shares":59260,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."}],"balance_after":59260,"derivative":{"exercise_price":67.5,"exercise_date":"2025-07-30","expiration_date":"2034-07-30","underlying":"Common Stock, par value $0.001 per share","underlying_shares":59260},"source":{"system":"sec-edgar","filing":"0001474506-25-000073","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000073/primary_doc.xml","form_type":"4"}},{"id":1187741,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81415,"kind":"organization","name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","position":1,"cik":"0002046615","reported_name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2025-03-31T13:20:04.000Z","date":"2024-07-30","kind":"purchase","planned":false,"acquired":true,"shares":76191,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."}],"balance_after":76191,"derivative":{"exercise_price":52.5,"exercise_date":"2025-07-30","expiration_date":"2034-07-30","underlying":"Common Stock, par value $0.001 per share","underlying_shares":76191},"source":{"system":"sec-edgar","filing":"0001474506-25-000073","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000073/primary_doc.xml","form_type":"4"}},{"id":1187740,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81415,"kind":"organization","name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","position":1,"cik":"0002046615","reported_name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2025-03-31T13:20:04.000Z","date":"2024-07-30","kind":"purchase","planned":false,"acquired":true,"shares":106667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."}],"balance_after":106667,"derivative":{"exercise_price":37.5,"exercise_date":"2025-07-30","expiration_date":"2034-07-30","underlying":"Common Stock, par value $0.001 per share","underlying_shares":106667},"source":{"system":"sec-edgar","filing":"0001474506-25-000073","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000073/primary_doc.xml","form_type":"4"}},{"id":1187739,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81415,"kind":"organization","name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","position":1,"cik":"0002046615","reported_name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T13:20:04.000Z","date":"2025-03-12","kind":"other","planned":false,"acquired":true,"shares":2560553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On March 12, 2025, the Ballantyne Trust effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via warrant exchange for 2,560,553 shares of Common Stock."}],"balance_after":2743591,"source":{"system":"sec-edgar","filing":"0001474506-25-000073","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000073/primary_doc.xml","form_type":"4"}},{"id":1187738,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81415,"kind":"organization","name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","position":1,"cik":"0002046615","reported_name":"John A. Ballantyne Revocable Living Trust dated 08/01/2017","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T13:20:04.000Z","date":"2024-11-14","kind":"other","planned":false,"acquired":true,"shares":132036,"price":31,"value":4093116.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."}],"balance_after":183039,"source":{"system":"sec-edgar","filing":"0001474506-25-000073","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000073/primary_doc.xml","form_type":"4"}},{"id":1187737,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81414,"kind":"person","name":"BALLANTYNE JOHN","position":1,"cik":"0001701346","reported_name":"BALLANTYNE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Common Warrant","published_at":"2025-03-31T12:54:53.000Z","date":"2025-03-12","kind":"other","planned":false,"acquired":false,"shares":132036,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"John A. Ballantyne Rev Trust 08/01/2017"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On November 14, 2024, in connection with the Conversion, the Ballantyne Trust was issued Series A Common Warrants to purchase Common Stock and Series B Common Warrants to purchase Common Stock, each at an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"On March 12, 2025, the Ballantyne Trust effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via warrant exchange for 2,560,553 shares of Common Stock."},{"field":"kind","element":"transactionCoding","label":"F5","text":"On March 12, 2025, the Ballantyne Trust effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via warrant exchange for 2,560,553 shares of Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"John A. Ballantyne is the trustee of the Ballantyne Trust and has sole voting and investment power over all securities owned by the Ballantyne Trust."}],"balance_after":0,"derivative":{"exercise_date":"2025-01-03","expiration_date":"2027-07-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":2560553},"source":{"system":"sec-edgar","filing":"0001474506-25-000072","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000072/primary_doc.xml","form_type":"4"}},{"id":1187736,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81414,"kind":"person","name":"BALLANTYNE JOHN","position":1,"cik":"0001701346","reported_name":"BALLANTYNE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Common Warrant","published_at":"2025-03-31T12:54:53.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":132036,"ownership":{"direct":false,"nature":"John A. Ballantyne Rev Trust 08/01/2017"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On November 14, 2024, in connection with the Conversion, the Ballantyne Trust was issued Series A Common Warrants to purchase Common Stock and Series B Common Warrants to purchase Common Stock, each at an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On November 14, 2024, in connection with the Conversion, the Ballantyne Trust was issued Series A Common Warrants to purchase Common Stock and Series B Common Warrants to purchase Common Stock, each at an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"John A. Ballantyne is the trustee of the Ballantyne Trust and has sole voting and investment power over all securities owned by the Ballantyne Trust."}],"balance_after":132036,"derivative":{"exercise_price":5.6,"exercise_date":"2025-01-03","expiration_date":"2027-07-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":2560553},"source":{"system":"sec-edgar","filing":"0001474506-25-000072","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000072/primary_doc.xml","form_type":"4"}},{"id":1187735,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81414,"kind":"person","name":"BALLANTYNE JOHN","position":1,"cik":"0001701346","reported_name":"BALLANTYNE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Common Warrant","published_at":"2025-03-31T12:54:53.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":132036,"ownership":{"direct":false,"nature":"John A. Ballantyne Rev Trust 08/01/2017"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On November 14, 2024, in connection with the Conversion, the Ballantyne Trust was issued Series A Common Warrants to purchase Common Stock and Series B Common Warrants to purchase Common Stock, each at an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"John A. Ballantyne is the trustee of the Ballantyne Trust and has sole voting and investment power over all securities owned by the Ballantyne Trust."}],"balance_after":132036,"derivative":{"exercise_price":5.6,"exercise_date":"2025-01-03","expiration_date":"2030-01-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":132036},"source":{"system":"sec-edgar","filing":"0001474506-25-000072","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000072/primary_doc.xml","form_type":"4"}},{"id":1187734,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81414,"kind":"person","name":"BALLANTYNE JOHN","position":1,"cik":"0001701346","reported_name":"BALLANTYNE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2025-03-31T12:54:53.000Z","date":"2024-07-30","kind":"purchase","planned":false,"acquired":true,"shares":59260,"ownership":{"direct":false,"nature":"John A. Ballantyne Rev Trust 08/01/2017"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"John A. Ballantyne is the trustee of the Ballantyne Trust and has sole voting and investment power over all securities owned by the Ballantyne Trust."}],"balance_after":59260,"derivative":{"exercise_price":67.5,"exercise_date":"2025-07-30","expiration_date":"2034-07-30","underlying":"Common Stock, par value $0.001 per share","underlying_shares":59260},"source":{"system":"sec-edgar","filing":"0001474506-25-000072","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000072/primary_doc.xml","form_type":"4"}},{"id":1187733,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81414,"kind":"person","name":"BALLANTYNE JOHN","position":1,"cik":"0001701346","reported_name":"BALLANTYNE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2025-03-31T12:54:53.000Z","date":"2024-07-30","kind":"purchase","planned":false,"acquired":true,"shares":76191,"ownership":{"direct":false,"nature":"John A. Ballantyne Rev Trust 08/01/2017"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"John A. Ballantyne is the trustee of the Ballantyne Trust and has sole voting and investment power over all securities owned by the Ballantyne Trust."}],"balance_after":76191,"derivative":{"exercise_price":52.5,"exercise_date":"2025-07-30","expiration_date":"2034-07-30","underlying":"Common Stock, par value $0.001 per share","underlying_shares":76191},"source":{"system":"sec-edgar","filing":"0001474506-25-000072","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000072/primary_doc.xml","form_type":"4"}},{"id":1187732,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81414,"kind":"person","name":"BALLANTYNE JOHN","position":1,"cik":"0001701346","reported_name":"BALLANTYNE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2025-03-31T12:54:53.000Z","date":"2024-07-30","kind":"purchase","planned":false,"acquired":true,"shares":106667,"ownership":{"direct":false,"nature":"John A. Ballantyne Rev Trust 08/01/2017"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"John A. Ballantyne is the trustee of the Ballantyne Trust and has sole voting and investment power over all securities owned by the Ballantyne Trust."}],"balance_after":106667,"derivative":{"exercise_price":37.5,"exercise_date":"2025-07-30","expiration_date":"2034-07-30","underlying":"Common Stock, par value $0.001 per share","underlying_shares":106667},"source":{"system":"sec-edgar","filing":"0001474506-25-000072","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000072/primary_doc.xml","form_type":"4"}},{"id":1187731,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81414,"kind":"person","name":"BALLANTYNE JOHN","position":1,"cik":"0001701346","reported_name":"BALLANTYNE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T12:54:53.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":4126,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4126,"source":{"system":"sec-edgar","filing":"0001474506-25-000072","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000072/primary_doc.xml","form_type":"4"}},{"id":1187730,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81414,"kind":"person","name":"BALLANTYNE JOHN","position":1,"cik":"0001701346","reported_name":"BALLANTYNE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T12:54:53.000Z","date":"2025-03-12","kind":"other","planned":false,"acquired":true,"shares":2560553,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"John A. Ballantyne Rev Trust 08/01/2017"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On March 12, 2025, the Ballantyne Trust effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via warrant exchange for 2,560,553 shares of Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"John A. Ballantyne is the trustee of the Ballantyne Trust and has sole voting and investment power over all securities owned by the Ballantyne Trust."}],"balance_after":2743591,"source":{"system":"sec-edgar","filing":"0001474506-25-000072","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000072/primary_doc.xml","form_type":"4"}},{"id":1187729,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81414,"kind":"person","name":"BALLANTYNE JOHN","position":1,"cik":"0001701346","reported_name":"BALLANTYNE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T12:54:53.000Z","date":"2024-11-14","kind":"other","planned":false,"acquired":true,"shares":132036,"price":31,"value":4093116.0,"ownership":{"direct":false,"nature":"John A. Ballantyne Rev Trust 08/01/2017"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 30, 2024, the issuer entered into a convertible promissory note and three warrant agreements (the \"Warrants\") with the John A. Ballantyne Rev Trust 08/01/2017 (the \"Ballantyne Trust\"), providing for the private placement of a secured convertible promissory note in the aggregate principal amount of $4,000,000 (the \"Note\"). The Note did not have a fixed conversion price, and the conversion price was dependent on the market price of the issuer's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On November 14, 2024, the issuer completed a public offering (the \"Offering\"). In connection with the Offering, the Ballantyne Trust agreed to convert approximately $4,093,112 of debt, which represented the outstanding principal and accrued interest under the Note, on substantially the same terms as the Offering, resulting in the issuance of 132,036 shares of Common Stock (plus 132,036 accompanying Series A common warrants (the \"Series A Common Warrants\") and 132,036 accompanying Series B common warrants (the \"Series B Common Warrants\")), based on a conversion price of $31.00 per share (the \"Conversion\"), which is equal to the consolidated closing bid price of the Common Stock on the Nasdaq Capital Market on November 12, 2024, the day prior to the date the securities purchase agreement governing the Conversion was executed."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"John A. Ballantyne is the trustee of the Ballantyne Trust and has sole voting and investment power over all securities owned by the Ballantyne Trust."}],"balance_after":183039,"source":{"system":"sec-edgar","filing":"0001474506-25-000072","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000072/primary_doc.xml","form_type":"4"}},{"id":1187762,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Common Warrant","published_at":"2025-03-31T08:17:33.000Z","date":"2025-03-12","kind":"other","planned":false,"acquired":false,"shares":6886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On November 14, 2024, in connection with the conversion of the Note, the reporting person was issued Series A common warrants (the \"Series A Common Warrants\") to purchase Common Stock and Series B common warrants (the \"Series B Common Warrants\") to purchase Common Stock, each with an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"On March 12, 2025, the reporting person effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via a warrant exchange for 133,532 shares of Common Stock."},{"field":"kind","element":"transactionCoding","label":"F5","text":"On March 12, 2025, the reporting person effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via a warrant exchange for 133,532 shares of Common Stock."}],"balance_after":0,"derivative":{"exercise_date":"2030-01-03","expiration_date":"2027-07-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":133532},"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187761,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Common Warrant","published_at":"2025-03-31T08:17:33.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":6886,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On November 14, 2024, in connection with the conversion of the Note, the reporting person was issued Series A common warrants (the \"Series A Common Warrants\") to purchase Common Stock and Series B common warrants (the \"Series B Common Warrants\") to purchase Common Stock, each with an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On November 14, 2024, in connection with the conversion of the Note, the reporting person was issued Series A common warrants (the \"Series A Common Warrants\") to purchase Common Stock and Series B common warrants (the \"Series B Common Warrants\") to purchase Common Stock, each with an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."}],"balance_after":6886,"derivative":{"exercise_price":5.6,"exercise_date":"2030-01-03","expiration_date":"2027-07-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":133532},"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187760,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Warrant","published_at":"2025-03-31T08:17:33.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":6886,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On November 14, 2024, in connection with the conversion of the Note, the reporting person was issued Series A common warrants (the \"Series A Common Warrants\") to purchase Common Stock and Series B common warrants (the \"Series B Common Warrants\") to purchase Common Stock, each with an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."}],"balance_after":6886,"derivative":{"exercise_price":5.6,"exercise_date":"2030-01-03","expiration_date":"2027-07-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":6886},"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187759,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-03-31T08:17:33.000Z","date":"2024-11-14","kind":"exercise","planned":false,"acquired":false,"price":214831,"reported_value":214831,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 14, 2024, the issuer completed a Qualified Financing and all outstanding principal and accrued but unpaid interest on the Note converted into common stock, par value $0.001 per share (the \"Common Stock\") at the Floor Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $200,000 (the \"Note\"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the \"Maturity Date\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the \"Note Balance\"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a \"Qualified Financing\"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the \"Floor Price\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $200,000 (the \"Note\"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the \"Maturity Date\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the \"Note Balance\"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a \"Qualified Financing\"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the \"Floor Price\")."}],"balance_after":0,"derivative":{"exercise_price":31.2,"underlying":"Common Stock, par value $0.001 per share","underlying_shares":6886},"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187758,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-03-31T08:17:33.000Z","date":"2024-07-18","kind":"purchase","planned":false,"acquired":true,"price":200000,"reported_value":200000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $200,000 (the \"Note\"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the \"Maturity Date\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the \"Note Balance\"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a \"Qualified Financing\"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the \"Floor Price\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $200,000 (the \"Note\"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the \"Maturity Date\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the \"Note Balance\"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a \"Qualified Financing\"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the \"Floor Price\")."}],"derivative":{"exercise_price":31.2,"underlying":"Common Stock, par value $0.001 per share","underlying_shares":6411},"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187757,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T08:17:33.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":2076,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":143617,"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187756,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T08:17:33.000Z","date":"2025-03-12","kind":"other","planned":false,"acquired":true,"shares":133532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On March 12, 2025, the reporting person effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via a warrant exchange for 133,532 shares of Common Stock."}],"balance_after":141541,"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187755,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T08:17:33.000Z","date":"2024-11-14","kind":"exercise","planned":false,"acquired":true,"shares":6886,"price":31.2,"value":214843.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 14, 2024, the issuer completed a Qualified Financing and all outstanding principal and accrued but unpaid interest on the Note converted into common stock, par value $0.001 per share (the \"Common Stock\") at the Floor Price."}],"balance_after":8009,"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187754,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T08:17:33.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":489,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1123,"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187753,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T08:17:33.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":362,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":634,"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187752,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T08:17:33.000Z","date":"2023-04-20","kind":"grant","planned":false,"acquired":true,"shares":121,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":272,"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187751,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T08:17:33.000Z","date":"2023-01-09","kind":"grant","planned":false,"acquired":true,"shares":29,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":151,"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187750,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T08:17:33.000Z","date":"2022-10-04","kind":"grant","planned":false,"acquired":true,"shares":44,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":122,"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187749,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T08:17:33.000Z","date":"2022-06-30","kind":"grant","planned":false,"acquired":true,"shares":34,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":78,"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187748,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T08:17:33.000Z","date":"2022-03-31","kind":"grant","planned":false,"acquired":true,"shares":25,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44,"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187747,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T08:17:33.000Z","date":"2021-12-31","kind":"grant","planned":false,"acquired":true,"shares":11,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19,"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1187746,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74451,"kind":"person","name":"Malave Luis","position":1,"cik":"0001395781","reported_name":"Malave Luis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T08:17:33.000Z","date":"2021-09-30","kind":"grant","planned":false,"acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8,"source":{"system":"sec-edgar","filing":"0001474506-25-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395781/000147450625000071/primary_doc.xml","form_type":"4"}},{"id":1188083,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Common Warrant","published_at":"2025-03-31T07:52:53.000Z","date":"2025-03-12","kind":"other","planned":false,"acquired":false,"shares":2078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On November 14, 2024, in connection with the conversion of the Note, the reporting person was issued Series A common warrants (the \"Series A Common Warrants\") to purchase Common Stock and Series B common warrants (the \"Series B Common Warrants\") to purchase Common Stock, each with an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"On March 12, 2025, the reporting person effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via a warrant exchange for 15,435 shares of Common Stock."},{"field":"kind","element":"transactionCoding","label":"F5","text":"On March 12, 2025, the reporting person effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via a warrant exchange for 15,435 shares of Common Stock."}],"balance_after":0,"derivative":{"exercise_date":"2030-01-03","expiration_date":"2027-07-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":40297},"source":{"system":"sec-edgar","filing":"0001474506-25-000070","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000147450625000070/primary_doc.xml","form_type":"4"}},{"id":1188082,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Common Warrant","published_at":"2025-03-31T07:52:53.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":2078,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On November 14, 2024, in connection with the conversion of the Note, the reporting person was issued Series A common warrants (the \"Series A Common Warrants\") to purchase Common Stock and Series B common warrants (the \"Series B Common Warrants\") to purchase Common Stock, each with an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On November 14, 2024, in connection with the conversion of the Note, the reporting person was issued Series A common warrants (the \"Series A Common Warrants\") to purchase Common Stock and Series B common warrants (the \"Series B Common Warrants\") to purchase Common Stock, each with an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."}],"balance_after":2078,"derivative":{"exercise_price":5.6,"exercise_date":"2025-01-03","expiration_date":"2027-07-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":40297},"source":{"system":"sec-edgar","filing":"0001474506-25-000070","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000147450625000070/primary_doc.xml","form_type":"4"}},{"id":1188081,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Warrant","published_at":"2025-03-31T07:52:53.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":2078,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On November 14, 2024, in connection with the conversion of the Note, the reporting person was issued Series A common warrants (the \"Series A Common Warrants\") to purchase Common Stock and Series B common warrants (the \"Series B Common Warrants\") to purchase Common Stock, each with an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."}],"balance_after":2078,"derivative":{"exercise_price":5.6,"exercise_date":"2025-01-03","expiration_date":"2030-01-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":2078},"source":{"system":"sec-edgar","filing":"0001474506-25-000070","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000147450625000070/primary_doc.xml","form_type":"4"}},{"id":1188080,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-03-31T07:52:53.000Z","date":"2024-11-14","kind":"exercise","planned":false,"acquired":true,"price":64831,"reported_value":64831,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 14, 2024, the issuer completed a Qualified Financing and all outstanding principal and accrued but unpaid interest on the Note converted into common stock, par value $0.001 per share (the \"Common Stock\") at the Floor Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $50,000 (the \"Note\"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the \"Maturity Date\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the \"Note Balance\"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a \"Qualified Financing\"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the \"Floor Price\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $50,000 (the \"Note\"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the \"Maturity Date\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the \"Note Balance\"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a \"Qualified Financing\"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the \"Floor Price\")."}],"balance_after":0,"derivative":{"exercise_price":31.2,"underlying":"Common Stock, par value $0.001 per share","underlying_shares":2078},"source":{"system":"sec-edgar","filing":"0001474506-25-000070","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000147450625000070/primary_doc.xml","form_type":"4"}},{"id":1188079,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-03-31T07:52:53.000Z","date":"2024-07-18","kind":"purchase","planned":false,"acquired":true,"price":50000,"reported_value":50000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $50,000 (the \"Note\"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the \"Maturity Date\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the \"Note Balance\"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a \"Qualified Financing\"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the \"Floor Price\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $50,000 (the \"Note\"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the \"Maturity Date\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the \"Note Balance\"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a \"Qualified Financing\"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the \"Floor Price\")."}],"derivative":{"exercise_price":31.2,"underlying":"Common Stock, par value $0.001 per share","underlying_shares":1603},"source":{"system":"sec-edgar","filing":"0001474506-25-000070","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000147450625000070/primary_doc.xml","form_type":"4"}},{"id":1188078,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T07:52:53.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":1896,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45632,"source":{"system":"sec-edgar","filing":"0001474506-25-000070","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000147450625000070/primary_doc.xml","form_type":"4"}},{"id":1188077,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T07:52:53.000Z","date":"2025-03-12","kind":"other","planned":false,"acquired":true,"shares":40297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On March 12, 2025, the reporting person effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via a warrant exchange for 15,435 shares of Common Stock."}],"balance_after":43736,"source":{"system":"sec-edgar","filing":"0001474506-25-000070","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000147450625000070/primary_doc.xml","form_type":"4"}},{"id":1188076,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T07:52:53.000Z","date":"2024-11-14","kind":"exercise","planned":false,"acquired":true,"shares":2078,"price":31.2,"value":64833.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 14, 2024, the issuer completed a Qualified Financing and all outstanding principal and accrued but unpaid interest on the Note converted into common stock, par value $0.001 per share (the \"Common Stock\") at the Floor Price."}],"balance_after":3439,"source":{"system":"sec-edgar","filing":"0001474506-25-000070","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000147450625000070/primary_doc.xml","form_type":"4"}},{"id":1188075,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T07:52:53.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":458,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1361,"source":{"system":"sec-edgar","filing":"0001474506-25-000070","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000147450625000070/primary_doc.xml","form_type":"4"}},{"id":1188074,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74467,"kind":"person","name":"Carter Erin Catherine","position":1,"cik":"0001993078","reported_name":"Carter Erin Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-31T07:52:53.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":903,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":903,"source":{"system":"sec-edgar","filing":"0001474506-25-000070","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993078/000147450625000070/primary_doc.xml","form_type":"4"}},{"id":1188694,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74449,"kind":"person","name":"Goode Paul","position":1,"cik":"0001622251","reported_name":"Goode Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B Common Warrant","published_at":"2025-03-29T01:43:16.000Z","date":"2025-03-12","kind":"other","planned":false,"acquired":true,"shares":796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On November 14, 2024, in connection with the conversion of the Note, the reporting person was issued Series A common warrants (the \"Series A Common Warrants\") to purchase Common Stock and Series B common warrants (the \"Series B Common Warrants\") to purchase Common Stock, each with an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"On March 12, 2025, the reporting person effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via a warrant exchange for 15,435 shares of Common Stock."},{"field":"kind","element":"transactionCoding","label":"F7","text":"On March 12, 2025, the reporting person effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via a warrant exchange for 15,435 shares of Common Stock."}],"balance_after":0,"derivative":{"exercise_date":"2025-01-03","expiration_date":"2027-07-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":15435},"source":{"system":"sec-edgar","filing":"0001474506-25-000069","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000069/primary_doc.xml","form_type":"4"}},{"id":1188693,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74449,"kind":"person","name":"Goode Paul","position":1,"cik":"0001622251","reported_name":"Goode Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B Common Warrant","published_at":"2025-03-29T01:43:16.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":796,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On November 14, 2024, in connection with the conversion of the Note, the reporting person was issued Series A common warrants (the \"Series A Common Warrants\") to purchase Common Stock and Series B common warrants (the \"Series B Common Warrants\") to purchase Common Stock, each with an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On November 14, 2024, in connection with the conversion of the Note, the reporting person was issued Series A common warrants (the \"Series A Common Warrants\") to purchase Common Stock and Series B common warrants (the \"Series B Common Warrants\") to purchase Common Stock, each with an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."}],"balance_after":796,"derivative":{"exercise_price":5.6,"exercise_date":"2025-01-03","expiration_date":"2027-07-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":15435},"source":{"system":"sec-edgar","filing":"0001474506-25-000069","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000069/primary_doc.xml","form_type":"4"}},{"id":1188692,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74449,"kind":"person","name":"Goode Paul","position":1,"cik":"0001622251","reported_name":"Goode Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Common Warrant","published_at":"2025-03-29T01:43:16.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":796,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On November 14, 2024, in connection with the conversion of the Note, the reporting person was issued Series A common warrants (the \"Series A Common Warrants\") to purchase Common Stock and Series B common warrants (the \"Series B Common Warrants\") to purchase Common Stock, each with an exercise price of $5.60 per share; provided that, at any time while the Series B Common Warrants are outstanding, the holder could exercise the Series B Common Warrants on a cashless basis pursuant to an alternate cashless exercise option, pursuant to which the holder of the Series B Common Warrant had the right to receive an aggregate number of shares of Common Stock equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash exercise rather than a cashless exercise of the Series B Common Warrant and (ii) 3.0 (the \"Alternative Cashless Exercise\")."}],"balance_after":796,"derivative":{"exercise_price":5.6,"exercise_date":"2025-01-03","expiration_date":"2030-01-03","underlying":"Common Stock, par value $0.001 per share","underlying_shares":796},"source":{"system":"sec-edgar","filing":"0001474506-25-000069","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000069/primary_doc.xml","form_type":"4"}},{"id":1188691,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74449,"kind":"person","name":"Goode Paul","position":1,"cik":"0001622251","reported_name":"Goode Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Promissory Note","published_at":"2025-03-29T01:43:16.000Z","date":"2024-11-14","kind":"exercise","planned":false,"acquired":false,"price":24831,"reported_value":24831,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On November 14, 2024, the issuer completed a Qualified Financing and all outstanding principal and accrued but unpaid interest on the Note converted into Common Stock at the Floor Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On November 14, 2024, the issuer completed a Qualified Financing and all outstanding principal and accrued but unpaid interest on the Note converted into Common Stock at the Floor Price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On November 14, 2024, the issuer completed a Qualified Financing and all outstanding principal and accrued but unpaid interest on the Note converted into Common Stock at the Floor Price."}],"derivative":{"exercise_price":31.2,"underlying":"Common Stock, par value $0.001 per share","underlying_shares":796},"source":{"system":"sec-edgar","filing":"0001474506-25-000069","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000069/primary_doc.xml","form_type":"4"}},{"id":1188690,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74449,"kind":"person","name":"Goode Paul","position":1,"cik":"0001622251","reported_name":"Goode Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Promissory Note","published_at":"2025-03-29T01:43:16.000Z","date":"2024-07-18","kind":"purchase","planned":false,"acquired":true,"price":10000,"reported_value":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $10,000 (the \"Note\"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the \"Maturity Date\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the \"Note Balance\"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a \"Qualified Financing\"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the \"Floor Price\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 18, 2024, the reporting person purchased a convertible promissory note in the principal amount of $10,000 (the \"Note\"). The Note bears simple interest at the rate of eight percent (8%) per annum and is due and payable in cash on the earlier of: (a) the twelve (12) month anniversary of Note, or (b) the date of closing of a Qualified Financing (defined below) (the \"Maturity Date\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"If not sooner repaid, all outstanding principal and accrued but unpaid interest on the Note (the \"Note Balance\"), as of the close of business on the day immediately preceding the date of the closing of the next issuance and sale of capital stock of the Company, in a single transaction or series of related transactions, to investors resulting in gross proceeds to the Company of at least $500,000 (excluding indebtedness converted in such financing) (a \"Qualified Financing\"), will automatically be converted into that number of shares of equity securities of the Company sold in the Qualified Financing equal to the number of shares calculated by dividing (X) the Note Balance by (Y) an amount equal to the price per share or other unit of equity securities issued in such Qualified Financing, and otherwise on the same terms as the security issued in the Qualified Financing, provided that the conversion price per share shall not be lower than $31.20 (the \"Floor Price\")."}],"derivative":{"exercise_price":31.2,"underlying":"Common Stock, par value $0.001 per share","underlying_shares":321},"source":{"system":"sec-edgar","filing":"0001474506-25-000069","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000069/primary_doc.xml","form_type":"4"}},{"id":1188689,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74449,"kind":"person","name":"Goode Paul","position":1,"cik":"0001622251","reported_name":"Goode Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants to Purchase Common Stock","published_at":"2025-03-29T01:43:16.000Z","date":"2024-07-01","kind":"purchase","planned":false,"acquired":true,"shares":2100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 1, 2025, the reporting person purchased a promissory note in the principal amount of $14,000 and an accompanying warrant to purchase shares of common stock, par value $0.001 per share (the \"Common Stock\") at an exercise price of $99.00 per share."}],"balance_after":2100,"derivative":{"exercise_price":99,"exercise_date":"2024-07-01","expiration_date":"2029-07-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0001474506-25-000069","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000069/primary_doc.xml","form_type":"4"}},{"id":1188688,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74449,"kind":"person","name":"Goode Paul","position":1,"cik":"0001622251","reported_name":"Goode Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-03-29T01:43:16.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":3277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award is 100% vested."}],"balance_after":3277,"derivative":{"exercise_price":49,"expiration_date":"2034-06-14","underlying":"Common Stock, par value $0.001 per share","underlying_shares":3277},"source":{"system":"sec-edgar","filing":"0001474506-25-000069","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000069/primary_doc.xml","form_type":"4"}},{"id":1188687,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74449,"kind":"person","name":"Goode Paul","position":1,"cik":"0001622251","reported_name":"Goode Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-29T01:43:16.000Z","date":"2025-03-12","kind":"other","planned":false,"acquired":true,"shares":15435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"On March 12, 2025, the reporting person effected an Alternative Cashless Exercise of the Series B Common Warrants and exercised the warrants on a cashless basis via a warrant exchange for 15,435 shares of Common Stock."}],"balance_after":18989,"source":{"system":"sec-edgar","filing":"0001474506-25-000069","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000069/primary_doc.xml","form_type":"4"}},{"id":1188686,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74449,"kind":"person","name":"Goode Paul","position":1,"cik":"0001622251","reported_name":"Goode Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-29T01:43:16.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"On October 7, 2022, the reporting person entered into an into Intellectual Property Purchase Agreement (the \"IP Purchase Agreement\") with the issuer, pursuant to which the reporting person is entitled to certain specified milestone payments, payable in Common Stock, as set forth in the IP Purchase Agreement. Upon the achievement of the first and second milestones contemplated by the IP Purchase Agreement, the reporting person was issued 1,500 shares of Common Stock, pursuant to the terms of the IP Purchase Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On October 7, 2022, the reporting person entered into an into Intellectual Property Purchase Agreement (the \"IP Purchase Agreement\") with the issuer, pursuant to which the reporting person is entitled to certain specified milestone payments, payable in Common Stock, as set forth in the IP Purchase Agreement. Upon the achievement of the first and second milestones contemplated by the IP Purchase Agreement, the reporting person was issued 1,500 shares of Common Stock, pursuant to the terms of the IP Purchase Agreement."}],"balance_after":3554,"source":{"system":"sec-edgar","filing":"0001474506-25-000069","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000069/primary_doc.xml","form_type":"4"}},{"id":1188685,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74449,"kind":"person","name":"Goode Paul","position":1,"cik":"0001622251","reported_name":"Goode Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-29T01:43:16.000Z","date":"2024-11-14","kind":"exercise","planned":false,"acquired":true,"shares":796,"price":31.2,"value":24835.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On November 14, 2024, the issuer completed a Qualified Financing and all outstanding principal and accrued but unpaid interest on the Note converted into Common Stock at the Floor Price."}],"balance_after":2054,"source":{"system":"sec-edgar","filing":"0001474506-25-000069","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000069/primary_doc.xml","form_type":"4"}},{"id":1188684,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81435,"kind":"person","name":"Danzig Allen","position":1,"cik":"0001905433","reported_name":"Danzig Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-29T01:05:09.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":1498,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1922,"source":{"system":"sec-edgar","filing":"0001474506-25-000068","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000068/primary_doc.xml","form_type":"4"}},{"id":1188683,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81435,"kind":"person","name":"Danzig Allen","position":1,"cik":"0001905433","reported_name":"Danzig Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-29T01:05:09.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":229,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":424,"source":{"system":"sec-edgar","filing":"0001474506-25-000068","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000068/primary_doc.xml","form_type":"4"}},{"id":1188682,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81435,"kind":"person","name":"Danzig Allen","position":1,"cik":"0001905433","reported_name":"Danzig Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-29T01:05:09.000Z","date":"2022-10-04","kind":"grant","planned":false,"acquired":true,"shares":44,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":195,"source":{"system":"sec-edgar","filing":"0001474506-25-000068","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000068/primary_doc.xml","form_type":"4"}},{"id":1188681,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81434,"kind":"person","name":"Fischell Robert","position":1,"cik":"0001557104","reported_name":"Fischell Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-29T00:53:09.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":1498,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2045,"source":{"system":"sec-edgar","filing":"0001474506-25-000066","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000066/primary_doc.xml","form_type":"4"}},{"id":1188680,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81434,"kind":"person","name":"Fischell Robert","position":1,"cik":"0001557104","reported_name":"Fischell Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-29T00:53:09.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":229,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":547,"source":{"system":"sec-edgar","filing":"0001474506-25-000066","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000066/primary_doc.xml","form_type":"4"}},{"id":1188679,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81434,"kind":"person","name":"Fischell Robert","position":1,"cik":"0001557104","reported_name":"Fischell Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-29T00:53:09.000Z","date":"2021-08-24","kind":"grant","planned":false,"acquired":true,"shares":318,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":318,"source":{"system":"sec-edgar","filing":"0001474506-25-000066","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450625000066/primary_doc.xml","form_type":"4"}},{"id":1188710,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74453,"kind":"person","name":"Balo Andrew K","position":1,"cik":"0001323190","reported_name":"Balo Andrew K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-03-28T20:57:15.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":4490,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4490,"source":{"system":"sec-edgar","filing":"0001474506-25-000067","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323190/000147450625000067/primary_doc.xml","form_type":"4"}},{"id":1459454,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":74449,"kind":"person","name":"Goode Paul","position":1,"cik":"0001622251","reported_name":"Goode Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants to Purchase Common Stock","published_at":"2024-07-03T21:26:02.000Z","date":"2024-07-01","kind":"purchase","planned":false,"acquired":true,"shares":42000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired warrants to purchase 42,000 shares of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\") for an aggregate purchase price of $14,000. Each warrant entitles the holder thereof to purchase one share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $4.95 per share, and expires five years after issuance."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 1, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired warrants to purchase 42,000 shares of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\") for an aggregate purchase price of $14,000. Each warrant entitles the holder thereof to purchase one share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $4.95 per share, and expires five years after issuance."}],"balance_after":42000,"derivative":{"exercise_price":4.95,"exercise_date":"2024-07-01","expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001474506-24-000177","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000147450624000177/primary_doc.xml","form_type":"4"}},{"id":1460808,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":89206,"kind":"person","name":"SYCOFF DREW","position":1,"cik":"0001083139","reported_name":"SYCOFF DREW","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2024-07-03T17:39:00.000Z","date":"2024-07-01","kind":"purchase","planned":false,"acquired":true,"shares":138000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired warrants to purchase 138,000 shares of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\") for an aggregate purchase price of $46,000. Each warrant entitles the holder thereof to purchase one share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $4.95 per share, and expires five years after issuance."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 1, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired warrants to purchase 138,000 shares of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\") for an aggregate purchase price of $46,000. Each warrant entitles the holder thereof to purchase one share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $4.95 per share, and expires five years after issuance."}],"balance_after":138000,"derivative":{"exercise_price":4.95,"exercise_date":"2024-07-01","expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":138000},"source":{"system":"sec-edgar","filing":"0001474506-24-000178","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083139/000147450624000178/primary_doc.xml","form_type":"4"}},{"id":1536383,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":89206,"kind":"person","name":"SYCOFF DREW","position":1,"cik":"0001083139","reported_name":"SYCOFF DREW","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-24T18:31:49.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":182539.6,"price":1.26,"value":229999.896,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In addition to the purchase reported above, ownership includes: (i) 76,279 shares of common stock owned by Mr. Sycoff; and (ii) 116,501 common stock owned by Andrew Garrett, Inc. Mr. Sycoff has voting power and investment control over the shares of common stock held by Andrew Garrett, Inc. Alma Diversified Holdings LLC, an entity owned by Sharon Sycoff, the wife of Mr. Sycoff owns 2,575,938 shares of common stock. Sharon Sycoff has voting power and investment control over the shares held by Alma Diversified Holdings LLC and Mr. Sycoff disclaims beneficial ownership in the shares held by Alma Diversified Holdings LLC."}],"balance_after":2951257.6,"source":{"system":"sec-edgar","filing":"0001493152-24-015833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083139/000149315224015833/ownership.xml","form_type":"4"}},{"id":4270925,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":174809,"kind":"person","name":"podwalski david","position":1,"cik":"0001707814","reported_name":"podwalski david","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Option (Right to Buy)","published_at":"2017-06-28T18:02:41.000Z","date":"2017-06-26","kind":"grant","acquired":true,"shares":290585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over a three year period commencing on June 26, 2017."}],"balance_after":290585,"derivative":{"exercise_price":4.5,"expiration_date":"2027-06-26","underlying":"Common Stock, par value $0.001 per share","underlying_shares":290585},"source":{"system":"sec-edgar","filing":"0001178913-17-001954","document":"zk1720207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000117891317001954/zk1720207.xml","form_type":"4"}},{"id":4286717,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81434,"kind":"person","name":"Fischell Robert","position":1,"cik":"0001557104","reported_name":"Fischell Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-09T20:13:19.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units do not have a conversion or exercise price. The reporting person's original Form 4 included a conversion price of $1.98."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"After June 1, 2018, the common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer."}],"balance_after":22727,"derivative":{"exercise_price":0,"exercise_date":"2018-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001178913-17-001788","document":"zk1720121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000117891317001788/zk1720121.xml","form_type":"4/A","original_submission_date":"2017-06-07"}},{"id":4286716,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":175335,"kind":"person","name":"Hauck Michael","position":1,"cik":"0001708854","reported_name":"Hauck Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-09T15:22:35.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"After June 1, 2018, the common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer."}],"balance_after":22727,"derivative":{"exercise_price":0,"exercise_date":"2018-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001178913-17-001784","document":"zk1720120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000117891317001784/zk1720120.xml","form_type":"4"}},{"id":4286715,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":175335,"kind":"person","name":"Hauck Michael","position":1,"cik":"0001708854","reported_name":"Hauck Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2017-06-09T15:22:35.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":14894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over a one year period commencing on June 1, 2017."}],"balance_after":14894,"derivative":{"exercise_price":4.5,"expiration_date":"2027-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":14894},"source":{"system":"sec-edgar","filing":"0001178913-17-001784","document":"zk1720120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000117891317001784/zk1720120.xml","form_type":"4"}},{"id":4287224,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":175359,"kind":"person","name":"SCHWARTZ REVAN","position":1,"cik":"0001690043","reported_name":"SCHWARTZ REVAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-09T11:21:00.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units do not have a conversion or exercise price. The reporting person's original Form 4 included a conversion price of $1.98."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"After June 1, 2018, the common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer."}],"balance_after":22727,"derivative":{"exercise_price":0,"exercise_date":"2018-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001178913-17-001782","document":"a1720119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690043/000117891317001782/a1720119.xml","form_type":"4/A","original_submission_date":"2017-06-06"}},{"id":4287078,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":175342,"kind":"person","name":"Seff Leslie","position":1,"cik":"0001670027","reported_name":"Seff Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-09T11:19:25.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units do not have a conversion or exercise price. The reporting person's original Form 4 included a conversion price of $1.98."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"After June 1, 2018, the common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer."}],"balance_after":22727,"derivative":{"exercise_price":0,"exercise_date":"2018-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001178913-17-001780","document":"zk1720118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670027/000117891317001780/zk1720118.xml","form_type":"4/A","original_submission_date":"2017-06-06"}},{"id":4289546,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81434,"kind":"person","name":"Fischell Robert","position":1,"cik":"0001557104","reported_name":"Fischell Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-07T21:30:42.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer."}],"balance_after":22727,"derivative":{"exercise_price":1.98,"exercise_date":"2018-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001178913-17-001757","document":"zk1720103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000117891317001757/zk1720103.xml","form_type":"4"}},{"id":4289545,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":81434,"kind":"person","name":"Fischell Robert","position":1,"cik":"0001557104","reported_name":"Fischell Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to buy)","published_at":"2017-06-07T21:30:42.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":14894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over a one year period commencing on June 1, 2017."}],"balance_after":14894,"derivative":{"exercise_price":4.5,"expiration_date":"2027-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":14894},"source":{"system":"sec-edgar","filing":"0001178913-17-001757","document":"zk1720103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000117891317001757/zk1720103.xml","form_type":"4"}},{"id":4289679,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":92944,"kind":"person","name":"BOYDSTON ANGELA STRAND","position":1,"cik":"0001299164","reported_name":"BOYDSTON ANGELA STRAND","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2017-06-07T21:21:08.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":25252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"After June 1, 2018, the common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer."}],"balance_after":25252,"derivative":{"exercise_price":0,"exercise_date":"2018-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":25252},"source":{"system":"sec-edgar","filing":"0001178913-17-001759","document":"zk1720102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299164/000117891317001759/zk1720102.xml","form_type":"4"}},{"id":4289678,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":92944,"kind":"person","name":"BOYDSTON ANGELA STRAND","position":1,"cik":"0001299164","reported_name":"BOYDSTON ANGELA STRAND","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Strategy Officer"}}],"security":"Option (Right to Buy)","published_at":"2017-06-07T21:21:08.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":14894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over a one year period commencing on June 1, 2017."}],"balance_after":14894,"derivative":{"exercise_price":4.5,"expiration_date":"2027-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":14894},"source":{"system":"sec-edgar","filing":"0001178913-17-001759","document":"zk1720102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299164/000117891317001759/zk1720102.xml","form_type":"4"}},{"id":4291229,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":175342,"kind":"person","name":"Seff Leslie","position":1,"cik":"0001670027","reported_name":"Seff Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-06T17:57:29.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer."}],"balance_after":22727,"derivative":{"exercise_price":1.98,"exercise_date":"2018-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001178913-17-001727","document":"zk1720094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670027/000117891317001727/zk1720094.xml","form_type":"4"}},{"id":4291228,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":175342,"kind":"person","name":"Seff Leslie","position":1,"cik":"0001670027","reported_name":"Seff Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2017-06-06T17:57:29.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":14894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over a one year period commencing on June 1, 2017."}],"balance_after":14894,"derivative":{"exercise_price":4.5,"expiration_date":"2027-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":14894},"source":{"system":"sec-edgar","filing":"0001178913-17-001727","document":"zk1720094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670027/000117891317001727/zk1720094.xml","form_type":"4"}},{"id":4291268,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":175359,"kind":"person","name":"SCHWARTZ REVAN","position":1,"cik":"0001690043","reported_name":"SCHWARTZ REVAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-06T17:56:33.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are scheduled to vest on June 1, 2018, assuming continued service as a director through and on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The common stock underlying the restricted stock units may be issued on such date as the reporting person elects or upon termination of their service with the Issuer."}],"balance_after":22727,"derivative":{"exercise_price":1.98,"exercise_date":"2018-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001178913-17-001725","document":"zk1720093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690043/000117891317001725/zk1720093.xml","form_type":"4"}},{"id":4291267,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":175359,"kind":"person","name":"SCHWARTZ REVAN","position":1,"cik":"0001690043","reported_name":"SCHWARTZ REVAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2017-06-06T17:56:33.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":14894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over a one year period commencing on June 1, 2017."}],"balance_after":14894,"derivative":{"exercise_price":4.5,"expiration_date":"2027-06-01","underlying":"Common Stock, par value $0.001 per share","underlying_shares":14894},"source":{"system":"sec-edgar","filing":"0001178913-17-001725","document":"zk1720093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690043/000117891317001725/zk1720093.xml","form_type":"4"}},{"id":4351968,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":176953,"kind":"person","name":"Malka David","position":1,"cik":"0001556758","reported_name":"Malka David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Operations"}}],"security":"Option (Right to Buy)","published_at":"2017-04-14T20:20:49.000Z","date":"2017-04-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the employment agreement entered into by the Company's wholly owned subsidiary, A.D. Integrity Applications Ltd. and the Reporting Person, the grant of the options to purchase common stock is subject to the Company reaching certain corporate development milestones."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shall vest over a three year period beginning on the date of grant as set forth in Note 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The option shall expire upon the ten (10) year anniversary of the date of grant as set forth in Note 4."}],"balance_after":25000,"derivative":{"exercise_price":4.5,"underlying":"Common Stock, par value $0.001 per share","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001178913-17-001121","document":"zk1719817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000117891317001121/zk1719817.xml","form_type":"4"}},{"id":4351967,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":176953,"kind":"person","name":"Malka David","position":1,"cik":"0001556758","reported_name":"Malka David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Operations"}}],"security":"Option (Right to Buy)","published_at":"2017-04-14T20:20:49.000Z","date":"2017-04-13","kind":"grant","acquired":true,"shares":266617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall vest 50% upon CFDA approval and 50% upon FDA approval."}],"balance_after":266617,"derivative":{"exercise_price":7.75,"expiration_date":"2027-04-13","underlying":"Common Stock, par value $0.001 per share","underlying_shares":266617},"source":{"system":"sec-edgar","filing":"0001178913-17-001121","document":"zk1719817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000117891317001121/zk1719817.xml","form_type":"4"}},{"id":4351966,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":176953,"kind":"person","name":"Malka David","position":1,"cik":"0001556758","reported_name":"Malka David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Operations"}}],"security":"Option (Right to Buy)","published_at":"2017-04-14T20:20:49.000Z","date":"2017-04-13","kind":"grant","acquired":true,"shares":361875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On a fully diluted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest over a three-year period commencing on April 13, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On a fully diluted basis."}],"balance_after":361875,"derivative":{"exercise_price":4.5,"expiration_date":"2027-04-13","underlying":"Common Stock, par value $0.001 per share","underlying_shares":361875},"source":{"system":"sec-edgar","filing":"0001178913-17-001121","document":"zk1719817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000117891317001121/zk1719817.xml","form_type":"4"}},{"id":4374349,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":177571,"kind":"person","name":"GRAHAM JOHN A","position":1,"cik":"0001701726","reported_name":"GRAHAM JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option (Right to Buy)","published_at":"2017-03-22T21:44:12.000Z","date":"2017-03-20","kind":"grant","acquired":true,"shares":844130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over a three year period commencing on March 20, 2017."}],"balance_after":844130,"derivative":{"exercise_price":7.75,"expiration_date":"2027-03-20","underlying":"Common Stock, par value $0.001 per share","underlying_shares":844130},"source":{"system":"sec-edgar","filing":"0001178913-17-000855","document":"zk1719718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000117891317000855/zk1719718.xml","form_type":"4"}},{"id":4374348,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":177571,"kind":"person","name":"GRAHAM JOHN A","position":1,"cik":"0001701726","reported_name":"GRAHAM JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option (Right to Buy)","published_at":"2017-03-22T21:44:12.000Z","date":"2017-03-20","kind":"grant","acquired":true,"shares":559414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over a three year period commencing on March 20, 2017."}],"balance_after":559414,"derivative":{"exercise_price":5.41,"expiration_date":"2027-03-20","underlying":"Common Stock, par value $0.001 per share","underlying_shares":559414},"source":{"system":"sec-edgar","filing":"0001178913-17-000855","document":"zk1719718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000117891317000855/zk1719718.xml","form_type":"4"}},{"id":4374347,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":177571,"kind":"person","name":"GRAHAM JOHN A","position":1,"cik":"0001701726","reported_name":"GRAHAM JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option (Right to Buy)","published_at":"2017-03-22T21:44:12.000Z","date":"2017-03-20","kind":"grant","acquired":true,"shares":1673996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over a three year period commencing on March 20, 2017."}],"balance_after":1673996,"derivative":{"exercise_price":4.5,"expiration_date":"2027-03-20","underlying":"Common Stock, par value $0.001 per share","underlying_shares":1673996},"source":{"system":"sec-edgar","filing":"0001178913-17-000855","document":"zk1719718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506983/000117891317000855/zk1719718.xml","form_type":"4"}},{"id":4374704,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":92944,"kind":"person","name":"BOYDSTON ANGELA STRAND","position":1,"cik":"0001299164","reported_name":"BOYDSTON ANGELA STRAND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2017-03-22T16:17:09.000Z","date":"2017-03-20","kind":"grant","acquired":true,"shares":4445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Granted as restricted common stock, which will vest in equal monthly installments over a one year period commencing on March 20, 2017."}],"balance_after":4445,"source":{"system":"sec-edgar","filing":"0001178913-17-000851","document":"zk1719711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299164/000117891317000851/zk1719711.xml","form_type":"4"}},{"id":4374703,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":92944,"kind":"person","name":"BOYDSTON ANGELA STRAND","position":1,"cik":"0001299164","reported_name":"BOYDSTON ANGELA STRAND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2017-03-22T16:17:09.000Z","date":"2017-03-20","kind":"grant","acquired":true,"shares":13334,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Strand Strategy"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transferred to Strand Strategy by the Issuer pursuant to a Consulting Agreement, effective December 1, 2017, by and between the Issuer and Strand Strategy (the \"Agreement\"). Pursuant to the Agreement and the transactions contemplated thereby, and in consideration of Strand Strategy's performance of certain services under the Agreement, on March 20, 2017, the Board of Directors of the Issuer authorized the issuance of 13,334 shares of common stock, par value $0.001 per share, of the Issuer, to Strand Strategy. The Agreement indicates that such issuance is based on a $4.50 per share valuation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Transferred to Strand Strategy by the Issuer pursuant to a Consulting Agreement, effective December 1, 2017, by and between the Issuer and Strand Strategy (the \"Agreement\"). Pursuant to the Agreement and the transactions contemplated thereby, and in consideration of Strand Strategy's performance of certain services under the Agreement, on March 20, 2017, the Board of Directors of the Issuer authorized the issuance of 13,334 shares of common stock, par value $0.001 per share, of the Issuer, to Strand Strategy. The Agreement indicates that such issuance is based on a $4.50 per share valuation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Strand Strategy, of which the Reporting Person is the managing director. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":13334,"source":{"system":"sec-edgar","filing":"0001178913-17-000851","document":"zk1719711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299164/000117891317000851/zk1719711.xml","form_type":"4"}},{"id":4375005,"issuer":{"id":8422,"kind":"organization","name":"Glucotrack, Inc."},"owners":[{"id":175342,"kind":"person","name":"Seff Leslie","position":1,"cik":"0001670027","reported_name":"Seff Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2017-03-22T16:15:18.000Z","date":"2017-03-20","kind":"grant","acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transferred to the Reporting Person by the Issuer in consideration of the Reporting Person's performance of certain consulting services."}],"balance_after":3334,"source":{"system":"sec-edgar","filing":"0001178913-17-000849","document":"zk1719710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670027/000117891317000849/zk1719710.xml","form_type":"4"}}],"next_cursor":"2017-03-22T16:15:18.000000Z,4375005"}